Overview

Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI

Status:
Unknown status
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This is the first comparison of efficacy of Betaseron and Copaxone for treatment of relapsing forms of MS.
Phase:
Phase 4
Details
Lead Sponsor:
Stuart D Cook MD
Treatments:
(T,G)-A-L
Glatiramer Acetate
Interferon beta-1b